Latest News
-
Two hormones key to prostate cancer risk
Men have an increased risk of developing prostate cancer if their blood has high levels of free testosterone and a growth hormone, a conference hears today. Read more
-
Calorie labelling has small impact – is it enough?
Policy-makers should not be deterred by evidence of the limited impact of calorie labelling in fast food outlets, British experts said today. Read more
-
Hope for Alzheimer’s treatment opportunity
Scientists working on progressive neurodegeneration diseases have found that some of the changes could be halted during an “under-appreciated time window”. Read more
-
Peanut allergy immunotherapy not a cure
Immunotherapy for peanut allergy can provide some protection – but does not offer a permanent cure, according to research published today. Read more
-
Caution urged around antibiotic threat
The language used to describe antimicrobial resistance is counterproductive and unlikely to cut the overuse, experts say today. Read more
-
Cannabinoids not proven for treating mental heath
The efficacy of cannabinoids for the treatment of six major mental health disorders, including depression and anxiety, is not yet proven, researchers say today. Read more
-
Cancer patients’ metaphor ‘menu’ launched
A "menu metaphor" has been created to help doctors explain cancer to their patients. Read more
-
More than 300 million people have a rare disease
More than 300 million people worldwide are currently living with diseases that are classified as rare, according to the first analysis of its kind. Read more
-
Wild poliovirus type 3 eradicated globally
Wild poliovirus type 3 (WPV3) has been eradicated worldwide, it has been announced. Read more
-
Blood pressure drugs best taken at bedtime?
Hypertensive patients can have better control of their condition, and lower risk of adverse events by taking medications last thing at night rather than in the morning, researchers report today. Read more